Condition: Corneal Edema · Fuchs · Fuchs Dystrophy · Sponsor: Emmecell
This study will evaluate the safety and effectiveness of a single injection of EO2002 at one of two dose levels (150,000 or 500,000 magnetic human corneal endothelial cells \[mHCECs\]), compared with a placebo injection, in participants with corneal edema caused by corneal endothelial dysfunction.
This description comes directly from the study's public registry record.
Clinical Operations - Emmecell · 650-769-4232 · clinicaltrials@emmecell.com
Always discuss trial participation with your own doctor first.
| Clinical Site 1 | Menlo Park, California, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07729137